
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model
Taihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1420-1433
Open Access | Times Cited: 124
Taihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1420-1433
Open Access | Times Cited: 124
Showing 26-50 of 124 citing articles:
Downregulation of HNF4A enables transcriptomic reprogramming during the hepatic acute-phase response
Charlotte Ehle, Aishwarya Iyer, Yunchen Wu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Charlotte Ehle, Aishwarya Iyer, Yunchen Wu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Xiaoli Pan, Yanqiao Zhang
Chinese Medical Journal (2022) Vol. 135, Iss. 10, pp. 1172-1181
Open Access | Times Cited: 22
Xiaoli Pan, Yanqiao Zhang
Chinese Medical Journal (2022) Vol. 135, Iss. 10, pp. 1172-1181
Open Access | Times Cited: 22
Therapeutic advances in alcohol-associated hepatitis
Gyöngyi Szabó, Mark Thursz, Vijay H. Shah
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1279-1290
Open Access | Times Cited: 21
Gyöngyi Szabó, Mark Thursz, Vijay H. Shah
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1279-1290
Open Access | Times Cited: 21
HNF4α in Hepatocyte Health and Disease
Manasi Kotulkar, Dakota R. Robarts, Udayan Apte
Seminars in Liver Disease (2023) Vol. 43, Iss. 02, pp. 234-244
Open Access | Times Cited: 13
Manasi Kotulkar, Dakota R. Robarts, Udayan Apte
Seminars in Liver Disease (2023) Vol. 43, Iss. 02, pp. 234-244
Open Access | Times Cited: 13
RNA Nanomedicine: Delivery Strategies and Applications
Junho Byun, Yina Wu, Jin-Won Park, et al.
The AAPS Journal (2023) Vol. 25, Iss. 6
Closed Access | Times Cited: 13
Junho Byun, Yina Wu, Jin-Won Park, et al.
The AAPS Journal (2023) Vol. 25, Iss. 6
Closed Access | Times Cited: 13
Liver-derived extracellular vesicles from patients with hepatitis B virus-related acute-on-chronic liver failure impair hepatic regeneration by inhibiting on FGFR2 signaling via miR-218-5p
Senquan Zhang, Jie Yu, Keqiang Rao, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 833-849
Open Access | Times Cited: 12
Senquan Zhang, Jie Yu, Keqiang Rao, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 833-849
Open Access | Times Cited: 12
Self-assembling nanoparticles with antioxidant activity for ROS scavenging in liver cells
Valeria Nele, Stefania Melini, Virginia Campani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105490-105490
Open Access | Times Cited: 4
Valeria Nele, Stefania Melini, Virginia Campani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 94, pp. 105490-105490
Open Access | Times Cited: 4
Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology
Chandrashekhar Madasu, Zian Liao, Sydney E. Parks, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 19
Closed Access | Times Cited: 4
Chandrashekhar Madasu, Zian Liao, Sydney E. Parks, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 19
Closed Access | Times Cited: 4
RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment
Xinzhu Shan, Zhiqiang Zhao, Pingping Lai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Xinzhu Shan, Zhiqiang Zhao, Pingping Lai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
A novel strategy to dissect multifaceted macrophage function in human diseases
Keaton Karlinsey, Lili Qu, Alyssa Matz, et al.
Journal of Leukocyte Biology (2022) Vol. 112, Iss. 6, pp. 1535-1542
Closed Access | Times Cited: 18
Keaton Karlinsey, Lili Qu, Alyssa Matz, et al.
Journal of Leukocyte Biology (2022) Vol. 112, Iss. 6, pp. 1535-1542
Closed Access | Times Cited: 18
Cartilage-targeting mRNA-lipid nanoparticles rescue perifocal apoptotic chondrocytes for integrative cartilage repair
Xinning Yu, Tengjing Xu, Huimin Shi, et al.
Chemical Engineering Journal (2023) Vol. 465, pp. 142841-142841
Closed Access | Times Cited: 10
Xinning Yu, Tengjing Xu, Huimin Shi, et al.
Chemical Engineering Journal (2023) Vol. 465, pp. 142841-142841
Closed Access | Times Cited: 10
Management of alcoholic hepatitis: A clinical perspective
Philipp Kasper, Sonja Lang, Hans‐Michael Steffen, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2078-2095
Open Access | Times Cited: 10
Philipp Kasper, Sonja Lang, Hans‐Michael Steffen, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2078-2095
Open Access | Times Cited: 10
Nanoparticle: Pathogenesis, Innovative Diagnosis, and Therapy of Liver Fibrosis
Wen Lin, X Liu, Dejun Yang, et al.
ChemistrySelect (2025) Vol. 10, Iss. 7
Closed Access
Wen Lin, X Liu, Dejun Yang, et al.
ChemistrySelect (2025) Vol. 10, Iss. 7
Closed Access
HNF4A mitigates sepsis-associated lung injury by upregulating NCOR2/GR/STAB1 axis and promoting macrophage polarization towards M2 phenotype
Yuhang Yang, Ri Wen, Xinmei Huang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Yuhang Yang, Ri Wen, Xinmei Huang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Specific muscle targeted delivery of miR-130a loaded lipid nanoparticles: a novel approach to inhibit lipid accumulation in skeletal muscle and obesity
Yingqian Wang, Zeqiang Ma, Lele Jiang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Yingqian Wang, Zeqiang Ma, Lele Jiang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
mRNA therapy: A new frontier in regenerative medicine
Danna Xue, Yue Zhang, Anran Shen, et al.
Deleted Journal (2025)
Open Access
Danna Xue, Yue Zhang, Anran Shen, et al.
Deleted Journal (2025)
Open Access
Wogonoside ameliorates oxidative damage in tubular epithelial cells of diabetic nephropathy by modulating the HNF4A-NRF2 axis
Xiandeng Li, Shuyan Zhao, Li Mi, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114481-114481
Closed Access
Xiandeng Li, Shuyan Zhao, Li Mi, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114481-114481
Closed Access
MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma
Hao Zhang, Xiangxu Kong, Haoran Qu, et al.
Oncogene (2025)
Closed Access
Hao Zhang, Xiangxu Kong, Haoran Qu, et al.
Oncogene (2025)
Closed Access
Circularized Supramolecular Spherical Nucleic Acids Alleviates Liver Fibrosis through Blocking Upstream Activation and Reversing Activation State of Hepatic Stellate Cells
Xu Yao, Yu Fan, Zinan Zhao, et al.
ACS Nano (2025)
Closed Access
Xu Yao, Yu Fan, Zinan Zhao, et al.
ACS Nano (2025)
Closed Access
Systemic genome-epigenome analysis captures a lineage-specific super-enhancer for MYB in gastrointestinal adenocarcinoma
Fuyuan Li, Shangzi Wang, Lian Chen, et al.
Molecular Systems Biology (2025)
Open Access
Fuyuan Li, Shangzi Wang, Lian Chen, et al.
Molecular Systems Biology (2025)
Open Access
Spatial gene regulatory networks driving cell state transitions during human liver disease
Nigel L. Hammond, Syed Murtuza Baker, Sokratia Georgaka, et al.
EMBO Molecular Medicine (2025)
Open Access
Nigel L. Hammond, Syed Murtuza Baker, Sokratia Georgaka, et al.
EMBO Molecular Medicine (2025)
Open Access
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Mario Romeo, Marcello Dallio, Fiammetta Di Nardo, et al.
Livers (2025) Vol. 5, Iss. 2, pp. 21-21
Open Access
Mario Romeo, Marcello Dallio, Fiammetta Di Nardo, et al.
Livers (2025) Vol. 5, Iss. 2, pp. 21-21
Open Access
Balancing metabolism and regeneration in liver diseases through HNF4α targeting
Céline Van Dender, Jolien Vandewalle, Claude Libert
Trends in Endocrinology and Metabolism (2025)
Closed Access
Céline Van Dender, Jolien Vandewalle, Claude Libert
Trends in Endocrinology and Metabolism (2025)
Closed Access
Maternal Western diet is associated with distinct preclinical pediatric NAFLD phenotypes in juvenile nonhuman primate offspring
Michael J. Nash, Evgenia Dobrinskikh, Rachel C. Janssen, et al.
Hepatology Communications (2023) Vol. 7, Iss. 2, pp. e0014-e0014
Open Access | Times Cited: 9
Michael J. Nash, Evgenia Dobrinskikh, Rachel C. Janssen, et al.
Hepatology Communications (2023) Vol. 7, Iss. 2, pp. e0014-e0014
Open Access | Times Cited: 9
Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3
Qiuxiang Zheng, Cuiping Lu, Yu Lian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27473-e27473
Open Access | Times Cited: 3